Modeling & Simulation Strategies Must Be Integrated into Clinical Development

Read the interview of our President Bernard Orlandini, along with Marc Essodaigui, CEO of Active Biomarkers and Alexandre Durand-Salmon, CEO of Banook Group.

They share with us their expertise on how to optimize the outcomes of clinical trials using Modeling and Simulation, Biomarkers and cardiac safety.

↓↓ Read the full article below ↓↓

3 CEO’s Expert Opinion: On Biomarkers, Cardiac Safety, Modeling & Simulation.

French Tech Paris-Saclay
Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique